[Drugs for intravenous induction of anesthesia: propofol]

Anaesthesist. 2018 Feb;67(2):147-162. doi: 10.1007/s00101-017-0397-y.
[Article in German]

Abstract

In a series of articles dealing with hypnotics for induction of anesthesia, this article describes the development and current value of propofol. Its significance far exceeds that of a pure induction hypnotic (sedation in diagnostic and therapeutic procedures and on the intensive care unit). Propofol is also used for sedation in diagnostic and therapeutic procedures and on the intensive care unit. In the field of induction of anesthesia, the alternatives are barely used. Some contraindications are still controversial whereas others are no longer sufficiently anchored in the users' awareness (widespread off-label use). Adverse effects, such as injection pain, infection risk and propofol-related infusion syndrome (PRIS) could be significantly reduced by pharmacovigilance. With appropriate caution nearly the whole spectrum of anesthesiology patients can be treated using propofol. The hemodynamic side effects and the rare but potentially fatal PRIS are limitations. Further developments address the water solubility and the solubilizing agents of propofol.

Keywords: Drug-related side effects and adverse reactions; Off-label use; Pharmacodynamics; Pharmacokinetics; Propofol infusion syndrome.

MeSH terms

  • Anesthesia, Intravenous
  • Anesthetics, Intravenous / adverse effects*
  • Anesthetics, Intravenous / therapeutic use*
  • Humans
  • Hypnotics and Sedatives / adverse effects*
  • Hypnotics and Sedatives / therapeutic use*
  • Infusions, Intravenous
  • Intensive Care Units
  • Pharmacovigilance
  • Propofol / adverse effects*
  • Propofol / therapeutic use*

Substances

  • Anesthetics, Intravenous
  • Hypnotics and Sedatives
  • Propofol